Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin E Stryjewski

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Medicina|December 7, 2007
[Quality of care in diabetic patients receiving pharmacologic treatment]María A Lombraña, María E Capetta, Alejandro Ugarte, et al.
The Pediatric Infectious Disease Journal|May 11, 2016
A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure InfectionBartosz Korczowski, Tinatin Antadze, Manana Giorgobiani, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2024
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimensJürgen B Bulitta, Edward Fang, Martin E Stryjewski, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2012
Efficacy of telavancin in patients with specific types of complicated skin and skin structure infectionsMartin E Stryjewski, Steven L Barriere, William O'Riordan, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
TD-1792 versus vancomycin for treatment of complicated skin and skin structure infectionsMartin E Stryjewski, Peter D Potgieter, Yu-Ping Li, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Telavancin for hospital-acquired pneumonia: clinical response and 28-day survivalG Ralph Corey, Marin H Kollef, Andrew F Shorr, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumoniaPaul S Covington, J Michael Davenport, David A Andrae, et al.
International Journal of Antimicrobial Agents|July 11, 2009
Rhodococcus equi endocarditis in immunocompetent hosts: report of the first two casesMarie-Françoise Tripodi, Daniel Vigo, Emanuele Durante-Mangoni, et al.
American Heart Journal|April 13, 2004
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999Christopher H Cabell, Paul A Heidenreich, Vivian H Chu, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureusEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Medicina|December 7, 2007
[Quality of care in diabetic patients receiving pharmacologic treatment]María A Lombraña, María E Capetta, Alejandro Ugarte, et al.
The Pediatric Infectious Disease Journal|May 11, 2016
A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure InfectionBartosz Korczowski, Tinatin Antadze, Manana Giorgobiani, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2024
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimensJürgen B Bulitta, Edward Fang, Martin E Stryjewski, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2012
Efficacy of telavancin in patients with specific types of complicated skin and skin structure infectionsMartin E Stryjewski, Steven L Barriere, William O'Riordan, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
TD-1792 versus vancomycin for treatment of complicated skin and skin structure infectionsMartin E Stryjewski, Peter D Potgieter, Yu-Ping Li, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Telavancin for hospital-acquired pneumonia: clinical response and 28-day survivalG Ralph Corey, Marin H Kollef, Andrew F Shorr, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumoniaPaul S Covington, J Michael Davenport, David A Andrae, et al.
International Journal of Antimicrobial Agents|July 11, 2009
Rhodococcus equi endocarditis in immunocompetent hosts: report of the first two casesMarie-Françoise Tripodi, Daniel Vigo, Emanuele Durante-Mangoni, et al.
American Heart Journal|April 13, 2004
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999Christopher H Cabell, Paul A Heidenreich, Vivian H Chu, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureusEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Pageof 9